Vimarsana
Biggest News Aggregation in the World

Perseverance Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Perseverance Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Perseverance Capital Today - Breaking & Trending Today

Latin American Company Galactic Holdings Raises 10 Million In Financing Round - Vimarsana News

Latin American Company Galactic Holdings Raises 10 Million In Financing Round

Galactic Holdings, a cryptocurrency company in Latin America, announced the successful completion of a $10 million Pre-A private investment round.. The

LATAM Crypto Company Galactic Holdings Raises $10 Million in Pre-A ... - Vimarsana News

LATAM Crypto Company Galactic Holdings Raises $10 Million in Pre-A ...

LATAM Crypto Company Galactic Holdings Raises $10 Million in Pre-A ...

LATAM Crypto Company Galactic Holdings Raises $10 Million in Pre-A Funding Round - Vimarsana News

LATAM Crypto Company Galactic Holdings Raises $10 Million in Pre-A Funding Round

Galactic Holdings, has successfully raised $10 million in its Pre-A round. The investment was led by BAI Capital, with participation from Animoca Brands, Y2Z Ventures, Longling Capital, Head & Shoulders

Follow the Money: Spatial Omics, CAR-NK Cells, AI-Powered Biology - Vimarsana News

Follow the Money: Spatial Omics, CAR-NK Cells, AI-Powered Biology

December 21, 2020 December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more. $170M: Israeli ‘Digital Health First’ VC Firm OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spea...

CG Oncology Closes $47M Series D Financing - Vimarsana News

CG Oncology Closes $47M Series D Financing

CG Oncology, Inc., an Irvine, Calif.-based clinical-stage biopharmaceutical company focused on the development of novel oncolytic immunotherapies, closed a $47m Series D financing. The round was led by new investor Kissei Pharmaceutical Co., Ltd., with participation from existing investors ORI Healthcare Fund, Camford Capital and Perseverance Capital Management. The company intends to use the funds for the advancement of its late-stage clinical programs for its lead oncolytic immunotherapy, CG0070, including an ongoing global Phase 3 trial (BOND3) with CG0070 as a monotherapy for the treatme...